Staphylococcus aureus bacteraemia: does duration matter?

Lancet Infect Dis. 2020 Dec;20(12):1353-1354. doi: 10.1016/S1473-3099(20)30590-9. Epub 2020 Aug 4.

Authors

Steven Y C Tong¹, Todd C Lee²

Affiliations

¹ Victorian Infectious Diseases Service, The Royal Melbourne Hospital, and Doherty Department University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne 3000, VIC, Australia. Electronic address: steven.tong@mh.org.au.
² Research Institute of the McGill University Health Centre and the Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, QC, Canada.

PMID: 32763193
DOI: 10.1016/S1473-3099(20)30590-9

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Bacteremia* / drug therapy
Humans
Methicillin-Resistant Staphylococcus aureus*
Prospective Studies
Staphylococcal Infections* / drug therapy
Staphylococcus aureus